[Mechanism of the anti-arrhythmic action of phosphocreatine in acute myocardial ischemia].
The association between phosphocreatine's antifibrillatory action and its effect on the excitement propagation processes in the ischemic area was investigated under acute coronary arterial occlusion in dogs. Ischemia considerably reduced the amplitude, and increased the duration and time of onset, in local electrograms, and provoked cardiac fibrillation at the time of occlusion or during the recovery of coronary flow. A single intravenous injection of 300 mg/kg phosphocreatine eliminated cardiac fibrillation and largely prevented electrographic changes in the ischemized area. Phosphocreatinine, phosphocreatine's structural analogue, produced a similar effect. It is suggested that antiarrhythmic action of phosphocreatine and phosphocreatinine is mediated by their membrane effects.
D000208:Acute Disease; D000818:Animals; D000889:Anti-Arrhythmia Agents; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006329:Heart Conduction System / Q000187:drug effects; D007700:Kinetics; D010725:Phosphocreatine / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000097:blood / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D010725:Phosphocreatine; C025403:phosphocreatinine
O mekhanizme antiaritmicheskogo deĭstviia fosfokreatina pri ostroĭ ishemii miokarda.